FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

12780811000001105: Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1804301000001110 Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1804321000001115 Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Is a Mesalazine 1.2g gastro-resistant modified-release tablets 60 tablet true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Is pack of Mezavant XL 1200mg tablets (Takeda UK Ltd) false Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Has active ingredient Mesalazine false Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Has AMP Mezavant XL 1200mg tablets (Takeda UK Ltd) true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Takeda UK Ltd) 60 tablet 5 x 12 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start